All lobbying filings

SMITHBUCKLIN CORPORATION

Lobbying for ASTCT · Healthcare Society

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $70,000.00 income · posted Jul 21, 2025

Official filing document

Lobbying activity 3

Medical/Disease Research/Clinical Labs

- Appropriations - CAR-T Therapy clarification - Cures 2.0 Engagement - Cancer Moonshot - NIH Funding

Health Issues

ASTCT Appropriations Billing and Coding CAR-T Therapy Clarifications Cures 2.0 Engagement Revaccination of Immunosuppressed Patients Patient-Care Episode Financial Toxicity NIH Funding Cancer Moonshot Donor Leave Act The Accelerating Kids Access to Care Act Alleviating Barriers to Care Act

Medicare/Medicaid

- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - Patient Care Episode - Financial Toxicity - Cancer Moonshot - The Accelerating Kids Access to Care Act - Alleviating Barriers to Care Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.